Federal Food and Drug Administration officials have admitted to U.S. senators that they should have taken stronger action to stop a Wisconsin firm from making and distributing medical products potentially tainted with life-threatening bacteria . The contaminated products have been blamed in lawsuits for serious infections and the death of a 2-year-old child.
Instead of simply holding a meeting last August with officials from H&P Industries Inc. and the Triad Group of Hartland, Wis., the FDA should have followed two worrisome inspections and the regulatory session with a formal warning letter, an enforcement action that requires prompt and thorough response, said Jeanne Ireland, the FDA's assistant commissioner for legislation.
Such a letter would have served to "reinforce FDA concerns about GMP [good manufacturing practice] deviations," Ireland said in a letter sent late Thursday to Sen. Michael Bennet, D-Colo., and Sen. Lamar Alexander, R-Tenn. The letter followed an "internal retrospective review" of the agency's oversight of the company, she wrote. .. continue reading...
No comments:
Post a Comment